Capital World Investors
NVAX icon

Capital World Investors’s Novavax NVAX Stock Holding History

Capital World Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-294,294
Closed -$21.7M – 580
2022
Q1 		$21.7M Sell
294,294
-580,854
-66% -$51.8M ﹤0.01% 490
2021
Q4 		$125M Sell
875,148
-603,553
-41% -$104M 0.02% 355
2021
Q3 		$307M Buy
1,478,701
+860,867
+139% +$190M 0.05% 262
2021
Q2 		$131M Hold
617,834
– – 0.02% 352
2021
Q1 		$112M Sell
617,834
-567,908
-48% -$113M 0.02% 354
2020
Q4 		$132M Buy
1,185,742
+29,363
+3% +$3.12M 0.03% 322
2020
Q3 		$125M Buy
1,156,379
+712,151
+160% +$86.8M 0.03% 312
2020
Q2 		$37M Buy
+444,228
New +$17M 0.01% 381

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Capital World Investors's NVAX Position: Q2 2022 in Review

Capital World Investors sold out of Novavax (NVAX) in Q2 2022, closing a stake of 294,294 shares — an estimated $21.7M sold.

Capital World Investors first reported a position in NVAX in Q2 2020 and held it in 8 quarters. The position peaked at $307M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Capital World Investors reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Capital World Investors sold 294,294 Novavax shares in Q2 2022, an estimated $21.7M.
  • Capital World Investors first reported a position in Novavax in Q2 2020 and held it in 8 quarters.
  • Capital World Investors's Novavax position peaked at $307M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Capital World Investors's 13F filing for Q2 2022, filed 15 Aug 2022.